Russell Basser
Direktor/Vorstandsmitglied bei STARPHARMA HOLDINGS LIMITED
Profil
Russell Basser is currently a Director at Medical Developments International Ltd., an Independent Non-Executive Director at Starpharma Holdings Ltd., and the Chief Medical Officer at CSL Ltd.
(United States).
Previously, he worked at CSL Behring LLC as the Senior VP-Global Clinical Research & Development from 2014 to 2022.
Basser received his undergraduate and doctorate degrees from the University of Melbourne.
Aktive Positionen von Russell Basser
Unternehmen | Position | Beginn |
---|---|---|
STARPHARMA HOLDINGS LIMITED | Direktor/Vorstandsmitglied | 20.02.2023 |
MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED | Direktor/Vorstandsmitglied | 01.09.2023 |
CSL Ltd. (United States) | Technik-/Wissenschafts-/F&E-Leiter | - |
Ehemalige bekannte Positionen von Russell Basser
Unternehmen | Position | Ende |
---|---|---|
CSL Behring LLC
CSL Behring LLC BiotechnologyHealth Technology CSL Behring LLC researches, develops, manufactures, and markets biotherapies that are used to treat serious and rare conditions. It offers protein-based therapies in the areas of Bleeding Disorders, Fluid Replacement, Hereditary Angioedema, Immunoglobulin, Pulmonary, and Wound Healing Therapies. The company was founded in 2004 and is headquartered in King of Prussia, PA. | Technik-/Wissenschafts-/F&E-Leiter | 01.04.2022 |
Ausbildung von Russell Basser
University of Melbourne | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
STARPHARMA HOLDINGS LIMITED | Health Technology |
MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED | Health Technology |
Private Unternehmen | 2 |
---|---|
CSL Behring LLC
CSL Behring LLC BiotechnologyHealth Technology CSL Behring LLC researches, develops, manufactures, and markets biotherapies that are used to treat serious and rare conditions. It offers protein-based therapies in the areas of Bleeding Disorders, Fluid Replacement, Hereditary Angioedema, Immunoglobulin, Pulmonary, and Wound Healing Therapies. The company was founded in 2004 and is headquartered in King of Prussia, PA. | Health Technology |
CSL Ltd. (United States) |